| |
Part II: Application
of legal approaches, including article 169
| WP 8 |
Management and partner recruitment (WP 9 to 11)
WP Leader: Peter Lange, Germany |
| WP 9 |
Funding of cancer research in the 25 EU member
states and in countries with an R&D-affiliation with the
EU
WP Leader: Jan-Wilhelm Hartgerink, Netherlands |
| WP 10 |
Governance, legal and financial structure of a
possible European Economic Interest Grouping; towards a European
Cancer Institute
WP Leader: Ulrik Ringborg, Sweden |
| WP 11 |
Public-Private Partnership and Collaboration with
Industry.
WP Leader: David Kerr, UK |
| |
| Cross cutting issues |
 |
Improving Cancer Research collaboration with new
Member States of the European Union is led by Witold Zatonski
(Poland). |
|
Improving mobility of all involved in cancer
research in the European Union. This is led by Hemma Bauer
(Austria). |
|
